Apotek Produktion & Laboratorier AB
Apotek Produktion & Laboratorier AB, APL, faces a lot of challenges when taking its products from drug discovery to market. With Synch’s expertise in and an understanding of the pharmaceutical industry, it has been able to provide APL with full-service legal support and advice that supports APL’s business challenges.
What is Apotek Produktion & Laboratorier?
APL is one of the largest manufacturers of special pharmaceuticals in Europe and one of the leading contract developers and manufacturers in the field of life science in the Nordic countries. APL has 520 employees and an annual turnover exceeding MSEK 1200. APL is a dedicated partner for its customers, from drug discovery to market. For more information click here.
As APL is acting in a highly regulated market it is, of course, of the utmost importance to comply with all relevant regulations. Furthermore, APL needs to secure and enforce its ownership of relevant IP that has been developed in-house and make sure that its distribution and logistics is appropriately set up and managed globally. These are some of the many challenges that faces a business of this size and in this type of market.
Synch’s team of skilled lawyers, with knowledge from the pharmaceutical industry, needs to work closely with APL and its management, in order to be up-to-date with the changes in the industry and business. This is also important in order for Synch to be able to provide high-quality, full-service legal support, e.g. assistance with commercial contracts, regulatory matters, intellectual property questions and dispute resolution.
“Synch is a highly professional law firm with extensive experience and know-how. The lawyers are proactive and very supportive in a great variety of legal services and the firm is a dependable partner in business negotiations and dispute resolution. APL appreciates the close cooperation with co-founder Sara Sparring and her colleagues and we feel very confident with the legal advice and services which Synch provides us”, says Eva Sjökvist Saers, CEO of APL.